Evidence map›Paper›PMID 26829253›Full record

ArticleAIDS education and prevention : official publication of the International Society for AIDS Education2016

To Use a Rectal Microbicide, First Insert the Applicator: Gel and Applicator Satisfaction Among Young Men Who Have Sex With Men.

J Bauermeister, R Giguere, C Dolezal, C S Leu, I Febo, R D Cranston, K Mayer, I McGowan, A Carballo-Diéguez

Abstract read
In one paragraph

Article in AIDS education and prevention : official publication of the International Society for AIDS Education, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Acceptability of PC-1005 Gel Administered Rectally to HIV-1 Seronegative Adults at Three Different Volume Levels (MTN-037).AIDS education and prevention : official publication of the International Society for AIDS Education · 2022
    Article
  5. Article
  6. Article
  7. Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study).AIDS education and prevention : official publication of the International Society for AIDS Education · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. On-demand microbicide products: design matters.Drug delivery and translational research · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

J BauermeisterUniversity of Michigan School of Public Health, Center for Sexuality & Health Disparities (SexLab), Ann Arbor.
R GiguereColumbia University and New York State Psychiatric Institute, HIV Center for Clinical and Behavioral Studies, New York.
C DolezalColumbia University and New York State Psychiatric Institute, HIV Center for Clinical and Behavioral Studies, New York.
C S LeuColumbia University and New York State Psychiatric Institute, HIV Center for Clinical and Behavioral Studies, New York.
I FeboUniversity of Puerto Rico Medical Sciences Campus, Department of Pediatrics, Gama Project, San Juan, Puerto Rico.
R D CranstonUniversity of Pittsburgh, School of Medicine, Division of Infectious Disease, Pittsburgh, Pennsylvania.
K MayerFenway Institute, Fenway Health, Boston, Massachusetts.
I McGowanUniversity of Pittsburgh School of Medicine, Division of Gastroenterology, Hepatology and Nutrition, Pittsburgh, Pennsylvania.
A Carballo-DiéguezColumbia University and New York State Psychiatric Institute, HIV Center for Clinical and Behavioral Studies, New York.

Funding

The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Claude Ann Mellins · 2003 to 2026
$48.2M
Microbicide Safety and Acceptability in Young MenR01HD059533 · NICHD · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI MCGOWAN, IAN MICHAEL · 2009 to 2012
$6.6M
NICHD NIH HHS R01 HD059533NICHD NIH HHS R01 HD59533NIMH NIH HHS P30 MH043520NIMH NIH HHS P30-MH43520
6 · The paper itself

Abstract

We examined how experiences with a rectal placebo gel and applicator used with receptive anal intercourse (RAI) related to young men who have sex with men's (YMSM) likelihood of using a rectal microbicide gel and applicator in the future. An ethnically diverse sample of 95 YMSM (aged 18 to 30 years) were asked to insert hydroxyethylcellulose (HEC) placebo gel rectally before RAI during 12 weeks and report the product's acceptability (i.e., satisfaction with applicator and gel, respectively; perceived gel side effects; and sexual satisfaction when gel was used) and likelihood of future microbicide use. Main and interaction effects predicting future use intentions were tested using linear regression. We found a positive association between future use intentions and applicator satisfaction (b = .33, p < .001). In a subsequent interaction effects model, we found that greater gel satisfaction was associated with increased future use intentions; however, the strength of this relationship was magnified when YMSM reported greatest satisfaction with the rectal applicator. Applicator satisfaction may be a salient factor in YMSM's decision-making to use a rectal microbicide in the future. Although the importance of developing a satisfactory rectal microbicide gel for YMSM is undeniable for its future use, our results also emphasize the importance of developing strategies that increase YMSM's comfort and skill when using a rectal applicator. Future research examining how to optimize the design, properties, and characteristics of a rectal applicator as a strategy to promote greater satisfaction and use among YMSM is merited.

Indexed as

Homosexuality, MaleAdministration, RectalAnti-Infective AgentsDrug Delivery SystemsEthnicityGelsHIV InfectionsHumansMalePatient Acceptance of Health CarePatient CompliancePersonal SatisfactionQualitative ResearchSexual BehaviorYoung AdultAnti-Infective AgentsGels

Identifiers

PMID26829253
PMCPMC4942182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.